Melanotan I
ApprovedAfamelanotide · Scenesse
Melanotan I (afamelanotide) is a linear synthetic α-MSH analog with higher selectivity for MC1R than MT-II. FDA-approved as Scenesse for erythropoietic protoporphyria (EPP), where it reduces phototoxic pain by enhancing melanin production and UV protection. Research explores broader applications in vitiligo, polymorphous light eruption, and other photosensitive disorders.
Skin & CosmeticSexual Health